EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Seroprevalence of Chikungunya and O'nyong‐nyong Viruses in Senegal, West Africa

Prince Baffour Tonto iD, Mouhamad Sy, Ibrahima Mbaye Ndiaye, Mariama Toure, Amy Gaye, Mariama Aidara, Amadou Moctar Mbaye, Abdoulaye Kane Dia, Mamadou Alpha Diallo, Jules Francois Gomis, Mamadou Samb Yade, Younous Diedhiou und 6 weitere

Journal of Medical Virology · 2025-03 · 97 (3)

DOI: 10.1002/jmv.70282 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 03.03.2025. Verfasst von Prince Baffour Tonto und 17 weiteren Autor:innen. Beteiligte Einrichtung: Rutgers Global Health Institute, Rutgers University, New Brunswick, New Jersey, USA. Hauptthemen laut MEDLINE: Chikungunya Fever, Antibodies, Viral, Chikungunya virus, O'nyong-nyong Virus. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Arthritogenic alphaviruses such as chikungunya (CHIKV) and o'nyong‐nyong (ONNV) viruses have shown capacity to cause widespread epidemics, with recurrent and sporadic outbreaks occurring throughout sub‐Saharan Africa. We analyzed the seroprevalence for CHIKV and ONNV in 470 non‐febrile subjects from three regions in Senegal (Sindia, 2018; Thies, 2018; and Kedougou, 2022/2023) using retrospective samples. We assessed the presence of anti‐CHIKV IgG and neutralizing antibody titers against CHIKV and ONNV via enzyme‐linked immunosorbent assay (ELISA) and microneutralization tests, respectively, and determined risk factors of CHIKV and ONNV exposure by binary logistic regression. The overall alphavirus seroprevalence based on an anti‐CHIKV virus like particle (VLP) IgG ELISA was 38.5%, with rates varying geographically: Kedougou (48.6%), Thies (31.9%), and Sindia (14.9%). Neutralizing antibody titers revealed CHIKV and ONNV seroprevalence rates of 7.4% and 9.8%, respectively, with significant variations by region and age group. Cross‐reactivity analysis showed that 82.9% of CHIKV cases exhibited a neutralizing response to ONNV, while 71.7% of ONNV cases cross‐neutralized CHIKV. Residents of Thies had significantly higher odds of CHIKV infection (aOR, 3.147; 95% CI: 1.164–8.510) while ONNV infection was more likely in Kedougou (aOR, 3.888; 95% CI: 1.319–11.466). Furthermore, older age (> 40 years) was a significant risk factor both CHIKV (aOR, 2.094; 95% CI: 0.846–5.185) and ONNV infection (aOR, 2.745; 95% CI: 1.212–6.216). Our study confirms the co‐circulation of CHIKV and ONNV in Senegal, highlighting their geographic and demographic distribution. These findings underscore the need for continued surveillance, alphavirus testing, and tailored public health strategies to mitigate their impact in Senegal.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chikungunya FeverAntibodies, ViralChikungunya virusO'nyong-nyong VirusAlphavirus InfectionsHumansSeroepidemiologic StudiesSenegalMaleAdultFemaleMiddle AgedAdolescentYoung AdultAntibodies, NeutralizingChildRetrospective StudiesImmunoglobulin GAgedChild, PreschoolEnzyme-Linked Immunosorbent AssayRisk FactorsInfantAged, 80 and over

Stichwörter der Autor:innen

neutralizing antibodiessenegalseroprevalence

Substanzen

Antibodies, ViralAntibodies, NeutralizingImmunoglobulin G

Autor:innen und Institutionen

  • Rutgers Global Health Institute, Rutgers University, New Brunswick, New Jersey, USA.
  • Department of Medicine, Division of Allergy, Immunology, and Infectious Diseases and Child Health Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
  • International Research Training Center on Genomics and Health Surveillance (CIGASS), Cheikh Anta Diop University, Dakar, Senegal.
  • Laboratoire d'Ecologie Vectorielle et Parasitaire, Cheikh Anta Diop University, Dakar, Senegal.

ORCID-Profile: Prince Baffour Tonto, Bobby Brooke Herrera

Zitieren

APA

Tonto, P. B., Sy, M., Ndiaye, I. M., Toure, M., Gaye, A., Aidara, M., Mbaye, A. M., Dia, A. K., Diallo, M. A., Gomis, J. F., Yade, M. S., Diedhiou, Y., Dieye, B., Diongue, K., Seck, M. C., Badiane, A. S., Herrera, B. B., & Ndiaye, D. (2025). Seroprevalence of Chikungunya and O'nyong‐nyong Viruses in Senegal, West Africa. Journal of Medical Virology, 97(3). https://doi.org/10.1002/jmv.70282

Vancouver

Tonto PB, Sy M, Ndiaye IM, Toure M, Gaye A, Aidara M, et al. Seroprevalence of Chikungunya and O'nyong‐nyong Viruses in Senegal, West Africa. Journal of Medical Virology. 2025;97(3). doi:10.1002/jmv.70282

BibTeX
@article{Tonto2025,
  author = {Tonto, Prince Baffour and Sy, Mouhamad and Ndiaye, Ibrahima Mbaye and Toure, Mariama and Gaye, Amy and Aidara, Mariama and Mbaye, Amadou Moctar and Dia, Abdoulaye Kane and Diallo, Mamadou Alpha and Gomis, Jules Francois and Yade, Mamadou Samb and Diedhiou, Younous and Dieye, Baba and Diongue, Khadim and Seck, Mame Cheikh and Badiane, Aida S and Herrera, Bobby Brooke and Ndiaye, Daouda},
  title = {Seroprevalence of Chikungunya and O'nyong‐nyong Viruses in Senegal, West Africa},
  journal = {Journal of Medical Virology},
  year = {2025},
  volume = {97},
  number = {3},
  doi = {10.1002/jmv.70282}
}
Kostenlos starten →